Janney Montgomery Scott LLC Catalyst Pharmaceuticals, Inc. Transaction History
Janney Montgomery Scott LLC
- $35.8 Billion
- Q3 2024
A detailed history of Janney Montgomery Scott LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 22,922 shares of CPRX stock, worth $512,077. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,922
Previous 22,922
-0.0%
Holding current value
$512,077
Previous $355,000
28.45%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CPRX
# of Institutions
327Shares Held
94.6MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$418 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$180 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$139 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$127 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$67.4 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.3B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...